Correcting serum concentrations of organochlorine compounds by lipids: Alternatives to the organochlorine/total lipids ratio

Environment International

Volumn 35, Issue 7, 2009, Pages 1080-1085

  Porta, Miquel ^a,b,c   Jariod, Manuel ^a,d   López, Tomàs ^a,c   Pumarega, José ^a,c   Puigdomènech, Elisa ^a,b,c   Marco, Esther ^e   Malats, Núria ^a,f   Grimalt, Joan O ^e   Real, Francisco X ^a,f,g  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^e DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^f Centro Nacional de Investigaciones Oncológicas   (Spain)

^g UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Beta hexachlorocyclohexane; Dichlorodiphenyldichloroethane; Dichlorodiphenyltrichloroethane; Hexachlorobenzene; Lipids; Methods; Organochlorine compounds; Pancreatic neoplasms; Persistent organic pollutants (POPs); Polychlorinated biphenyls

Indexed keywords

BODY FLUIDS; CHLORINE COMPOUNDS; CHOLESTEROL; GAS CHROMATOGRAPHY; LIPIDS; POLYCHLORINATED BIPHENYLS;

DICHLORODIPHENYLDICHLOROETHANE; DICHLORODIPHENYLTRICHLOROETHANE; HEXACHLOROBENZENE; HEXACHLOROCYCLOHEXANES; METHODS; ORGANOCHLORINE COMPOUNDS; PANCREATIC NEOPLASMS; PERSISTENT ORGANIC POLLUTANTS;

ORGANIC POLLUTANTS;

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; CHLORPHENOTANE; CHOLESTEROL; HEXACHLOROBENZENE; LIPID; ORGANOCHLORINE DERIVATIVE; POLYCHLORINATED BIPHENYL; TRIACYLGLYCEROL;

DDD; DDT; EPIDEMIOLOGY; HCH; HEXACHLOROBENZENE; LIPID; ORGANOCHLORINE; PCB; SERUM;

ARTICLE; BLOOD CHEMISTRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GAS CHROMATOGRAPHY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL;

EID: 68049098029     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2009.06.004     Document Type: Article

References (53)

1. Alcock R., Bashkin V., Bisson M., Brecher R.W., van Bree L., Chrast R., et al. Joint WHO/Convention Task Force on the Health Aspects of Air Pollution. Health risks of persistent organic pollutants from long-range transboundary air pollution. Copenhagen: World Health Organization, Regional Office for Europe; 2003. (http://www.euro.who.int/Document/e78963.pdf).
2. Alguacil J., Porta M., Malats N., Kauppinen T., Kogevinas M., Benavides F.G., et al. Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer. Carcinogenesis 23 (2002) 101-106
3. Alguacil J., Porta M., Kauppinen T., Malats N., Kogevinas M., and Carrato A. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer. Int J Cancer 107 (2003) 635-641
4. Armitage P., Berry G., and Matthews J.N.S. Statistical methods in medical research. 4th. ed. (2002), Blackwell, Oxford
5. Baris D., Kwak L.W., Rothman N., Wilson W., Manns A., Tarone R.E., et al. Blood levels of organochlorines before and after chemotherapy among non-Hodgkin's lymphoma patients. Cancer Epidemiol Biomarkers Prev 9 (2000) 193-197
6. Bernert J.T., Turner W.E., Patterson Jr. D.G., and Needham L.L. Calculation of serum "total lipid" concentrations for the adjustment of persistent organohalogen toxicant measurements in human samples. Chemosphere 68 (2007) 824-831
7. Chaler R., Vilanova R., Santiago-Silva M., Fernandez P., and Grimalt J.O. Enhanced sensitivity in the analysis of trace organochlorine compounds by negative-ion mass spectrometry with ammonia as reagent gas. J Chromatogr A 823 (1998) 73-79
8. Covaci A., Voorspoels S., Thomsen C., van Bavel B., and Neels H. Evaluation of total lipids using enzymatic methods for the normalization of persistent organic pollutant levels in serum. Sci Total Environ 366 (2006) 361-366
9. Crous-Bou M. Clinical and environmental influences on the prevalence of mutations in the K-ras oncogene in patients with pancreatic ductal adenocarcinoma [doctoral dissertation; dir.: Porta M]. Barcelona: Universitat Autònoma de Barcelona; 2009 [cited 2009 May 11]. Catalan and English. Available from: http://www.imim.es/programesrecerca/epidemiologia/en_documentsgrecm.html.
10. Crous-Bou M., Porta M., López T., Jariod M., Malats N., Alguacil J., et al. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Pancreas 35 (2007) 135-141
11. Crous-Bou M., De Vivo I., Porta M., Pumarega J.A., López T., Alguacil J., et al. CYP1B1 polymorphisms and K-ras mutations in patients with pancreatic ductal adenocarcinoma. Dig Dis Sci 53 (2008) 1417-1421
12. De Roos A.J., Hartge P., Lubin J.H., Colt J.S., Davis S., Cerhan J.R., et al. Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma. Cancer Res 65 (2005) 11,214-11,226
13. Glynn A.W., Granath F., Aune M., Atuma S., Darnerud P.O., and Bjerselius R. Organochlorine in Swedish women: determinants of serum concentrations. Environ Health Perspect 111 (2003) 349-355
14. Hoppin J.A., Tolbert P.E., Holly E.A., Brock J.W., Korrick S.A., Altshul L.M., et al. Pancreatic cancer and serum organochlorine levels. Cancer Epidemiol Biomark Prev 9 (2000) 199-205
15. Hue O., Marcotte J., Berrigan F., Simoneau M., Doré J., and Marceau P. Increased plasma levels of toxic pollutants accompanying weight loss induced by hypocaloric diet or by bariatric surgery. Obes Surg 16 (2006) 1145-1154
16. Iwasaki M., Inoue M., Sasazuki S., Kurahashi N., Itoh H., Usuda M., et al. Plasma organochlorine levels and subsequent risk of breast cancer among Japanese women: a nested case-control study. Sci Total Environ 402 (2008) 176-183
17. James R.A., Hertz-Picciotto I., Willman E., Keller J.A., and Charles M.J. Determinants of serum polychlorinated biphenyls and organochlorine pesticides measured in women from the child health and development study cohort, 1963-1967. Environ Health Perspect 110 (2002) 617-624
18. Kleinbaum D.G., Kupper L.L., Muller K.E., and Nizam A. Applied regression analysis and other multivariable methods. 3rd edition (1998), Duxbury Press, Pacific Grove, CA
19. López-Carrillo L., Torres-Sánchez L., López-Cervantes M., Blair A., Cebria M.E., and Uribe M. The adipose tissue to serum dichlorodiphenyldichloroethane (DDE) ratio: some methodological considerations. Environ Res 81 (1999) 142-145
20. Malats N., Casals T., Porta M., Guarner L., Estivill X., and Real FX for the PANKRAS II Study Group. The cystic fibrosis transmembrane regulator (CFTR) ΔF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreas cancer. Gut 48 (2001) 70-74
21. McLean D., Pearce N., Langseth H., Jäppinen P., Szadkowska-Stanczyk I., Persson B., et al. Cancer mortality in workers exposed to organochlorine compounds in the pulp and paper industry: an international collaborative study. Environ Health Perspect 114 (2006) 1007-1012
22. Mendez M.A., Vioque J., Porta M., Morales E., López T., Malats N., et al. Estimating dietary intakes from a brief questionnaire: a simulation study of reliability in a molecular epidemiologic study of pancreatic and biliary diseases. Eur J Epidemiol 21 (2006) 417-426
23. Morales E., Porta M., Vioque J., López T., Mendez M.A., Pumarega J., et al., for the PANKRAS II Study Group. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health 61 (2007) 641-649
24. Norén K., Weistrand C., and Karpe F. Distribution of PCB congeners, DDE, hexachlorobenzene, and methylsulfonyl metabolites of PCB and DDE among various fractions of human blood plasma. Arch Environ Contam Toxicol 37 (1999) 408-414
25. Otero R., Santiago-Silva M., and Grimalt J.O. Hexachlorocyclohexanes in human blood serum. J Chromatogr A 778 (1997) 87-94
26. Petreas M., Smith D., Hurley S., Jeffrey S.S., Gilliss D., and Reynolds P. Distribution of persistent, lipid-soluble chemicals in breast and abdominal adipose tissues: lessons learned from a breast cancer study. Cancer Epidemiol Biomarkers Prev 13 (2004) 416-424
27. Phillips D.L., Pirkle J.L., Burse V.W., Bernert Jr. J.T., Henderson L.O., and Needham L.L. Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol 18 (1989) 495-500
28. Porta M. Role of organochlorine compounds in the etiology of pancreatic cancer: a proposal to develop methodological standards. Epidemiology 12 (2001) 272-276
29. In: Porta M. (Ed). A dictionary of epidemiology. 5th edition (2008), Oxford University Press, New York 69 226
30. Porta M., Malats N., Jariod M., Grimalt J.O., Rifà J., Carrato A., et al. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. Lancet 354 (1999) 2125-2129
31. Porta M., Malats N., Guarner L., Carrato A., Rifà J., Salas A., et al. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. J Epidemiol Community Health 53 (1999) 702-709
32. Porta M., Costafreda S., Malats N., Guarner L., Soler M., Gubern J.M., et al. Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. Eur J Epidemiol 16 (2000) 533-541
33. Porta M., Zumeta E., Ruiz L., Jariod M., Malats N., Marco E., et al. The influence of age and gender on serum concentrations of p, p′DDT, p, p′DDE and the DDT/DDE ratio in subjects with exocrine pancreatic cancer. Organohalogen Compounds 59 (2002) 351-354
34. Porta M., Ruiz L., Jariod M., Zumeta E., Malats N., Marco E., et al. Correlations among serum concentrations of highly prevalent organochlorine compounds in patients with exocrine pancreatic cancer. Organohalogen Compounds 55 (2002) 307-310
35. Porta M., Fabregat X., Malats N., Guarner L., Carrato A., de Miguel A., et al. Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. Clin Transl Oncol. 7 (2005) 189-197
36. Porta M., Grimalt J.O., Jariod M., Ruiz L., Marco E., López T., et al. Influence of lipid and lifestyle factors upon correlations between highly prevalent organochlorine compounds in patients with exocrine pancreatic cancer. Environ Int 33 (2007) 946-954
37. Porta M., Pumarega J., Ferrer-Armengou O., López T., Alguacil J., Malats N., et al. Timing of blood extraction in epidemiologic and proteomic studies: results and proposals from the PANKRAS II Study. Eur J Epidemiol 22 (2007) 577-588
38. Porta M., Puigdomènech E., Ballester F., Selva J., Ribas-Fitó N., Llop S., et al. Monitoring concentrations of persistent organic pollutants in the general population: the international experience. Environ Int 34 (2008) 546-561
39. Porta M., Ferrer-Armengou O., Pumarega J., López T., Crous-Bou M., Alguacil A., et al. Exocrine pancreatic cancer clinical factors were related to timing of blood extraction and influenced serum concentrations of lipids. J Clin Epidemiol 61 (2008) 695-704
40. Porta M., Bosch de Basea M., Benavides F.G., López T., Fernandez E., Alguacil J., et al. Differences in serum concentrations of organochlorine compounds by occupational social class in pancreatic cancer. Environ Res 108 (2008) 370-379
41. Porta M., Pumarega J., López T., Jariod M., Marco E., Grimalt J.O., and for the PANKRAS II Study Group. Influence of tumor stage, symptoms and time of blood draw on serum concentrations of organochlorine compounds in exocrine pancreatic cancer. Cancer Causes Control 20 (2009) 10.1007/s10552-009-9383-2
42. Real F.X., Malats N., Lesca G., Porta M., Chopin S., Lenoir G.M., et al. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreas cancer. Gut 50 (2002) 653-657
43. Reed L., Buchner V., and Tchounwou P.B. Environmental toxicology and health effects associated with hexachlorobenzene exposure. Rev Environ Health 22 (2007) 213-243
44. Ribas-Fitó N., Torrent M., Carrizo D., Júlvez J., Grimalt J.O., and Sunyer J. Exposure to hexachlorobenzene during pregnancy and children's social behavior at 4 years of age. Environ Health Perspect 115 (2007) 447-450
45. Schisterman E.F., Whitcomb B.W., Louis G.M., and Louis .TA. Lipid adjustment in the analysis of environmental contaminants and human health risks. Environ Health Perspect 113 (2005) 853-857
46. Soler M., Malats N., Porta M., Guarner L., Costafreda S., Gubern J.M., et al. Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. Dig Dis Sci 44 (1999) 2469-2477
47. Spinelli J.J., Ng C.H., Weber J.P., Connors J.M., Gascoyne R.D., Lai A.S., et al. Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer 121 (2007) 2767-2775
48. To-Figueras J., Sala M., Otero R., Barrot C., Santiago-Silva M., Rodamilans M., et al. Metabolism of hexachlorobenzene in humans: association between serum levels and urinary metabolites in a highly exposed population. Environ Health Perspect 105 (1997) 78-83
49. United Nations Environment Programme (UNEP), Global Environment Facility (GEF), Inter-Organization Programme for the Sound Management of Chemicals (IOMC). Regionally based assessment of persistent toxic substances. Global report 2003. Châtelaine, Switzerland: UNEP Chemicals; 2003. (http://www.chem.unep.ch/pts/gr/Global_Report.pdf).
50. Verner M.A., Charbonneau M., López-Carrillo L., and Haddad S. Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studies. Environ Health Perspect 116 (2008) 886-892
51. Wolff M.S., Zeleniuch-Jacquotte A., Dubin N., and Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 9 (2000) 271-277
52. Wolff M.S., Britton J.A., Teitelbaum S.L., Eng S., Deych E., Ireland K., et al. Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev 14 (2005) 2224-2236
53. Wolff M.S., Anderson H.A., Britton J.A., and Rothman N. Pharmacokinetic variability and modern epidemiology-the example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort. Cancer Epidemiol Biomarkers Prev 16 (2007) 1925-1930